Literature DB >> 9616137

Interferon-gamma increases expression of chemokine receptors CCR1, CCR3, and CCR5, but not CXCR4 in monocytoid U937 cells.

D Zella1, O Barabitskaja, J M Burns, F Romerio, D E Dunn, M G Revello, G Gerna, M S Reitz, R C Gallo, F F Weichold.   

Abstract

Chemokine receptors (CR), which can mediate migration of immune cells to the site of inflammation, also function as coreceptors for human immunodeficiency virus (HIV) entry into CD4+ T lymphocytes and antigen-presenting cells. We demonstrate here that interferon-gamma (IFN-gamma) increases the expression of chemokine receptors CCR1, CCR3, and CCR5 in monocytoid U937 cells as detected by cell surface molecule labeling and mRNA expression, as well as by intracellular calcium mobilization and cell migration in response to specific ligands. The increased expression of these chemokine receptors also results in an enhanced HIV-1 entry into cells. Our data provide evidence for a relationship of cellular pathways that are induced by IFN-gamma with those that regulate chemokine receptor expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9616137

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

1.  IL-12 as well as IL-2 upregulates CCR5 expression on T cell receptor-triggered human CD4+ and CD8+ T cells.

Authors:  Y F Yang; M Tomura; M Iwasaki; T Mukai; P Gao; S Ono; J P Zou; G M Shearer; H Fujiwara; T Hamaoka
Journal:  J Clin Immunol       Date:  2001-03       Impact factor: 8.317

2.  High glucose enhances HIV entry into T cells through upregulation of CXCR4.

Authors:  Xiqian Lan; Kang Cheng; Nirupama Chandel; Rivka Lederman; Aakash Jhaveri; Mohammad Husain; Ashwani Malhotra; Pravin C Singhal
Journal:  J Leukoc Biol       Date:  2013-08-02       Impact factor: 4.962

3.  Human retinal microglia express candidate receptors for HIV-1 infection.

Authors:  V T Pham; L Wen; P McCluskey; M C Madigan; P L Penfold
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

4.  CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells.

Authors:  Jason Caulfield; Maria Fernandez; Vladimir Snetkov; Tak Lee; Catherine Hawrylowicz
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

5.  Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor.

Authors:  Erinn S Raborn; Guy A Cabral
Journal:  J Pharmacol Exp Ther       Date:  2010-01-20       Impact factor: 4.030

6.  CXCL12 secreted from adipose tissue recruits macrophages and induces insulin resistance in mice.

Authors:  Dayea Kim; Jaeyoon Kim; Jong Hyuk Yoon; Jaewang Ghim; Kyungmoo Yea; Parkyong Song; Soyeon Park; Areum Lee; Chun-Pyo Hong; Min Seong Jang; Yonghoon Kwon; Sehoon Park; Myoung Ho Jang; Per-Olof Berggren; Pann-Ghill Suh; Sung Ho Ryu
Journal:  Diabetologia       Date:  2014-04-18       Impact factor: 10.122

7.  Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.

Authors:  Erinn S Raborn; Melissa Jamerson; Francine Marciano-Cabral; Guy A Cabral
Journal:  Life Sci       Date:  2014-04-15       Impact factor: 5.037

8.  Absence of donor Th17 leads to augmented Th1 differentiation and exacerbated acute graft-versus-host disease.

Authors:  Tangsheng Yi; Dongchang Zhao; Chia-Lei Lin; Chunyan Zhang; Ying Chen; Ivan Todorov; Thomas LeBon; Fouad Kandeel; Stephen Forman; Defu Zeng
Journal:  Blood       Date:  2008-07-02       Impact factor: 22.113

9.  Gp120-mediated cytotoxicity of human brain microvascular endothelial cells is dependent on p38 mitogen-activated protein kinase activation.

Authors:  Naveed Ahmed Khan; Francescopaolo Di Cello; Monique Stins; Kwang Sik Kim
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

10.  Azelnidipine protects myocardium in hyperglycemia-induced cardiac damage.

Authors:  Vasundhara Kain; Sandeep Kumar; Amrutesh S Puranik; Sandhya L Sitasawad
Journal:  Cardiovasc Diabetol       Date:  2010-12-01       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.